Drug intelligence / Profile preview

VISCODEW

Development stage: Unknown
Lead developer: Protech Remedies
Administration: Ophthalmic

Overview

**VISCODEW** is a marketed topical ophthalmic artificial-tear formulation from Protech Remedies for dry eye disease. It contains hydroxypropyl methylcellulose 0.3% w/v, dextran 70 0.1% w/v, and glycerin 0.2% w/v. These hydrophilic lubricating agents supplement the tear film and coat the ocular surface, providing temporary relief of dryness-associated burning, irritation, and discomfort. ([protechremedies.com](https://protechremedies.com/product/viscodew-eye-drops/))

Brand names: VISCODEW
Other names: VISCODEW Eye DropsViscodew Eye Drop (Bak Free)

Beyond the preview

Go deeper on VISCODEW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VISCODEW.

Explore the full profile